fulvestrant has been researched along with Ischemic Attack, Transient in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, D; Lü, Q; Wang, R; Xu, J; Zhang, GY; Zhang, QG | 1 |
1 other study(ies) available for fulvestrant and Ischemic Attack, Transient
| Article | Year |
|---|---|
Inhibition of MLK3-MKK4/7-JNK1/2 pathway by Akt1 in exogenous estrogen-induced neuroprotection against transient global cerebral ischemia by a non-genomic mechanism in male rats.
Topics: Animals; Blotting, Western; Chromones; Disease Models, Animal; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Hippocampus; Immunohistochemistry; Immunoprecipitation; Ischemic Attack, Transient; Male; MAP Kinase Kinase 7; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase Kinase Kinase 11; Morpholines; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Serine; Signal Transduction | 2006 |